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Early diagnostics is a key factor in the success of many initiatives; including missions 
into deep space, rapid response to disease outbreaks, and long-term care of comorbidities of 
chronic conditions. Unfortunately, in many of the aforementioned scenarios, it is impossible to 
transport the patient to the hospital, or even a point of care. Thus, there is a clear need for rapid, 
portable, and inexpensive diagnostic replacements for common tests such as the western blot, 
and gel electrophoresis. We believe that by applying the concept of isotachophoresis (ITP), or 
electrophoretic mobility stacking, to microfluidic chips, we can develop a portable, inexpensive, 
and easy to use replacement for gel electrophoresis and the western blot. We use soft 
lithographic techniques to fabricate our device. Further, we apply a carbon black membrane 
between our electrode and main flow channel to improve electric efficiency. In this 
correspondence, we develop a mathematical model for previous ITP experiments, improve the 
electrical efficiency of our separation experiment, extend previous experiments on dyes to a 
relevant biomarker, avidin, and explore changing the analyte media to a relevant biofluid, human 
serum. Further, we define the critical bubble voltage of our experiments in human serum. We 
find that we were able to successfully extend our technology to work with avidin and human 
serum. Further, we were able to reduce the required voltage for separation of dye within our 
device from 1800 to 200 volts. Finally, we developed a mathematical model that fits our dye 
experiments. In the future, we will look to change our biofluid to whole blood, and look into 
using DNA as an analyte. Further, we will look to build upon our existing mathematical model 
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 Achieving a manned trip to Mars is a tremendous long-term goal set by numerous public 
and private organizations. Further, a successful mission would mark the first step in the long 
journey towards extraterrestrial colonization. A goal that SpaceX hopes to achieve by the 2030s.1 
The six month journey into deep space presents a myriad of crew health, safety, and 
performance challenges.2 Specifically, astronauts are at a higher risk of developing: bone 
demineralization, cardiovascular dysfunction, and muscular dystrophy.3 As is true with any 
affliction, early diagnosis is the first step to a positive patient outcome. Therefore, 
aforementioned challenges make screening for disease, establishing deviatio ns from personal 
health norms, and detecting viral and bacterial infection of crewmembers, cabin air, and cabin 
water vital to the success of any deep space venture.4 
Protein and DNA separation, namely western blots and gel electrophoresis are two 
crucial diagnostic tools.5 Unfortunately, the equipment required to drive these processes is far 
too bulky to be practical for missions into deep space. Therefore, the long-term goal of this 
project is to develop a lightweight, and compact diagnostic device capable of simultaneously 
separating proteins and DNA. Furthermore, our final device will be inexpensive, rapid easy to 
use, and require minimal sample volume. 
We believe a microfluidic approach is the optimal solution to the problem of long-term 
space-efficient crew diagnostics due to the fact that microfluidic devices tend to achieve 




Our chip utilizes a physical phenomenon known as isotachophoresis (ITP). ITP 
simultaneously focuses, and separates analytes based on their electrophoretic mobility. ITP is 
achieved by flowing the analyte(s) between a leading electrolyte (LE), which has a higher 
electrophoretic mobility than all analytes, and a tailing electrolyte (TE), which has a lower 
electrophoretic mobility than all analytes, and applying an electric field across the device. ITP 
within batch systems is a widely researched.7 Further, ITP has been applied to continuous 
systems in a process known as free flow isotachophoresis (FFITP) in select cases. Some of these 
cases include the separation of analytes from whole blood, specifically high-electrophoretic 
mobility protein separations, and the analysis of pathogenic bacteria.8,9,10,11,12 We believe that 
ITP within a microfluidic device can be an effective replacement for western blots and gel 
electrophoresis. 
Unfortunately, FFITP has many roadblocks preventing its use within more generalized 
systems, such as our proposed full western blot and gel electrophoresis system. These roadblocks 
include: Joule heating, bubble generation due to the electrolysis of water, and unwanted electro-
osmotic flow.13 The major problems with generalized ITP within FFITP are caused by the 
required voltage to resolve proteins and DNA strands with relatively low electrophoretic 
mobilitys. In order to resolve these proteins, the applied voltage must be increased, which 
increases the current within the electrolytes, causing the aforementioned roadblocks. 
Furthermore, the required voltage to achieve these separations would be in the thousands. 
Equipment capable of driving such a voltage would not meet our weight, space, and cost 
specifications. 
We circumvent the high required voltage by doping the PDMS between the electrodes 
and the main flow channel with carbon black, reducing the overall electrical resistance between 
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the two electrodes. The lowered voltage reduces Joule heating, and overall current within the 
electrolytes. The reduced current, in turn suppresses bubble generation. Further, we utilize 
HPMC to suppress electro-osmotic flow.13 
In the past we have applied this technology to dyes in order to show that FFITP is 
possible within a continuous process.13 In this correspondence, we expand our technology to 
relevant biomarkers, namely avidin, while simultaneously adding a mathematical model to our 
results with dyes. Finally, we bring our idealized model closer to practicality by changing the 
media to human serum. 
Finally, it should be noted that this technology has uses outside of diagnostics within 
deep space exploration. In fact, this technology is a valuable tool in any scenario where portable, 
and inexpensive diagnostics is deemed desirable. More specifically, we believe that this 
technology can provide diagnostic value in crisis situations in under-developed countries such as 
the recent Zika outbreak. We envision our technology being useful after biological markers have 
been determined as a quick on-site diagnostic tool. Further, due to the “easy-to-use” nature of 
our technology, we believe that FFITP can be applied to at home screening for patients who are 
at high risk for comorbidities with diagnosed conditions. For example, a patient who is 
diagnosed with diabetes is at a high risk for comorbidities such as fatty liver disease, and cancer. 
In serious cases, patients could perform monthly at home self-screens, potentially providing the 







2.1 ITP Background 
 ITP stacks analytes by their electrophoretic mobility. More specifically, the analyte with 
the highest electrophoretic mobility will be found closest to the electrode opposite the charge of 




 (Equation 1) 
Where: 
µ is the electrophoretic mobility 
vd is the drift velocity in a uniform electric field 
E is the electric field 
It should be noted that the drift velocity, and therefore the electrophoretic mobility, of a 
species is dependent on both the species itself, and the media the species is present in. 
 Furthermore, for ITP to be successful, the five following conditions must be true5: 
1. The LE, TE, and all analytes must have the same charge sign. 
2. The electrophoretic mobility of all analytes must be higher than the electrophoretic 
mobility of the tailing electrolyte within the tailing electrolyte. 
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3. The electrophoretic mobility of all analytes must be higher than the electrophoretic 
mobility of the tailing electrolyte within the analytes. 
4. The electrophoretic mobility of all analytes must be lower than the electrophoretic 
mobility of the leading electrolyte within the leading electrolyte. 
5. The electrophoretic mobility of all analytes must be lower than the electrophoretic 
mobility of the leading electrolyte within the analytes. 
2.2 ITP Theory 
 ITP can be modeled using the basic mass transfer equations. We define the z-axis as the 
parallel to the direction of flow, we define the y-axis as the direction of an arrow that points from 
one electrode to the other. This leaves the x-axis as the direction that points up and down the 
channel. We assume that there is no change within the x-axis. 
Basic mass transfer equation: 
𝜕𝐶
𝜕𝑡
+ ∇ ∙ (?⃑? 𝐶) = 𝐷(∇2𝐶) − 𝜇 ∗ ?⃑⃑?(∇ ∙ (?⃑? 𝐶)) (Equation 2) 
Where: 
v is the velocity 
E is the electric field 
D is the diffusivity 
t is time 
µ is the electrophoretic mobility of a species 
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C is the concentration of a species 
Assuming that our system has reached steady state, and we are sufficiently far down the 
channel such that no change occurs in the z direction, noting that the electric field is only in the y 







 (Equation 3) 







∑ 𝑧𝑖𝐷𝑖∇𝐶𝑖𝑖  (Equation 4) 
Where: 
σ is the conductivity of the electrolyte 
i is any chemical species 
zi is the valency of a chemical species 
Di is the diffusivity of a chemical species 
Ci is the concentration of a chemical species 
j and F are constants 
 Equations 3 and 4 can be numerically coupled in order to solve for the expected 
concentration profile. 
2.3.1 Electrolysis of Water 
 The electrolysis of water poses a significant practical problem for all FFITP systems due 
to the high current within the electrolytes and the analyte.  
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𝐻2𝑂(𝑙) → 𝐻2(𝑔) +
1
2
𝑂2(𝑔) (Equation 5) 
 The problem, as highlighted in the above reaction, occurs due to the rapid insertion of 
gasses into the microfluidic channel. These gasses form bubbles, which causes the device to 
perform unpredictably, limiting the overall usefulness of the device. 
 The electrolysis reaction puts a practical ceiling on the voltage that can be applied to our 
device. This ceiling is dependent on the current created in the device. Kinetically, electrolysis is 
linearly dependent on the current.14 Therefore, by Ohm’s law, the maximum allowed voltage 
scales linearly with the maximum allowed current. Further, the maximum allowed voltage scales 
with R-1. This relationship is quite important when moving from one media to another. 
2.3.2 Quinhydrone 
 In order to combat the electrolysis reaction, we flow quinhydrone on the sides of our 
channels. Quinhydrone is an electron donor/acceptor complex between hydroquinone, and p-
benzoquinone. Furthermore, hydroquinone itself can act as an electron acceptor, and therefore 
function as a suppressor of the electrolysis of water.15 More specifically, quinhydrone accepts 
electrons that would be used for the electrolysis of water. 
 
 






Materials and Methods 
3.1 Device Geometry 
 Our device, as shown in figure 2, consisted of one main flow channel with 5 inlet and 
outlet channels. The main flow channel was 1 cm long 1 mm wide, and 50 microns high. 
Furthermore, the gap between the main flow channel and the electrodes was 100 microns thick. 
 
Figure 2: Bright field image of the device 
3.2 Fabrication Overview 
 We fabricated our microfluidic device using a standard multistage soft lithographic 
process. This process consisted of developing a negative mold of the device, applying doped 
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PDMS to the device by hand, then pouring and curing PDMS on top of the negative mold. 
Finally, we attached the PDMS to a glass coverslip. 
3.2.1 Negative Mold Fabrication 
 We fabricated the negative mold by pouring SU-8 3050 (Microchem Corp), a negative 
photoresist, onto a silica wafer. We then spun the photoresist down to its desired height. In the 
case of this experiment, this desired height was 50 microns. We then softbaked the wafer at 65oC 
for two minutes, followed by a subsequent 95oC softbake for three minutes. The primary 
softbake prevented heat shocking the wafer, which could have caused the negative mold to crack. 
Next, we aligned a transparent mask and developed the photoresist using UV light. After 
exposure, we softbaked the wafer for 5 more minutes at 95oC, then bathed the wafer in SU 
developer. We then went through two more minutes of 65oC softbaking, three more minutes of 
95oC softbaking, and finished with a 200oC hardbake for three hours. 
3.2.2 Carbon Black Application Process 
 We began by scraping the carbon black (25% wt) doped PDMS onto a pipette tip. We 
then dragged the tip of the pipette down the negative mold, in between the negatives of the main 
flow channel and the electrode channel. Next, we took a razor, positioned it such that the razor 
lined up parallel to the main flow channel, and at a low angle, scraped perpendicularly to the 
main flow channel. The low angle prevented scratching the negative mold. This cleaned off any 
excess carbon black from the main flow channel. Note that we applied this process to both sides 




3.2.3 PDMS Fabrication 
 We poured a 1:10 mixture of curing agent to PDMS on top of the silica wafer. This 
mixture was allowed to cure for 1 hour at 85oC. We then gently removed the PDMS from the 
mold. We then punched holes into each inlet and outlet using a .75 mm biopsy punch (Ted 
Pella). After this, we exposed the device, and a glass coverslip to oxygen plasma (Jetlight, Model 
42A) and attached the PDMS to the glass coverslip. The PDMS and coverslip were allowed to 
cure overnight 
3.2.4 Gallium Electrode 
 The electrode in our device was made of gallium. We fabricated the electrode by melting 
solid gallium on a hot plate at 40oC. Note that we placed the device on the same hot plate as the 
gallium, in order to prevent heat shocking the device when we input the gallium into the 
electrode channel. We then transported the liquefied gallium from the hot plate, into the 
electrode channel using a syringe. Before the gallium solidified, we placed metal posts in the 
inlet channels to create a future location to connect the power source to our device. After the 




Figure 3: Fabrication process overview16 
3.3 Chemicals and Reagents 
 All chemicals used in this paper were purchased from Sigma-Aldrich unless otherwise 
stated. 
3.3.1 Crosslinked PDMS 
 We made the crosslinked PDMS by adding a 1:10 solution of curing agent and PDMS to 









3.3.2 Carbon Black Doped PDMS 
 We make the carbon black doped PDMS by taking the same solution used to make the 
crosslinked PDMS. We then added carbon black such that the carbon black made up 25% of the 
total weight of the mixture. Finally, we mixed the mixture in a Thinky ARM 310. 
3.3.3 Tailing Electrolyte 
 Using a pipette, we mixed a sample of 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 20 mM Bis-Tris, .1% HPMC, and 1% Tween 20 by 
volume. In separation experiments, we prepared stock solutions of 1 mg/mL rhodamine B and 1 
mg/mL fluorescein in advance, and diluted by a factor of ten within the tailing electrolyte. In 
concentration experiments, no analyte was included within the tailing electrolyte. 
3.3.4 Leading Electrolyte 
 Using a pipette, we mixed a sample of 10 mM HCl, 20 mM Bis-Tris, .1% HPMC and 1% 
Tween 20. 
3.3.5 Quinhydrone 
 We made the quinhydrone solution by mixing a solution such that 1 mg/mL of 
hydroquinone and 1 mg/mL of p-benzoquinone was present, and allowing such a solution to 





3.3.6 Human Serum 
 Our human serum was supplied from pooled donors, and stored in a freezer. Upon 
unfreezing, we aliquotted the serum into 4 mL samples. Each sample was, at most, unfrozen two 
times, and refrozen one time within our care. 
3.3.7 Concentration Analyte 
 Concentration analytes were prepared by mixing 3900 mL of DI water with 100 mL of 
analyte. Our analyte stock solutions were 2.5 µM Avidin-FITC, and 1 mg/mL fluorescein. 
3.4 Flow Control 
 We connected pressurized house gas to an elveflow control system. The pressurized gas 
was applied to a sample tube containing reagents, which flowed through a flowmeter and into the 






Figure 4: Flow control diagram 
3.5.1 Concentration Experiments 
 In concentration experiments, we flowed quinhydrone through channels 1 and 5. We 
simultaneously flowed the LE through channel 2 and the TE through channel 4. Furthermore, we 
flowed the analyte of interest through channel 3. We varied the flow rate of the analyte from 2 
µL/min to 50 µL/min. We flowed both the TE and the LE at the same flowrate as the analyte, 
whereas the quinhydrone flow was driven at half the flowrate of the analyte. Practically 
speaking, so long as the width of the quinhydrone profile within the channel is sufficiently large 
to block bubble formation, the quinhydrone flow rate can be altered as desired, in order to 
determine what outlet the analyte ends up in, however we keep the quinhydrone flow rate 
consistent throughout our experiments. We then applied an electric field across the main flow 
channel, perpendicular to flow, inducing analyte focusing. Voltages from 0 to 200 V were 
applied across the 1.2 mm gap between electrodes. The electric field was applied such that the 
analyte was attracted towards the electrode closest to the LE. This is dependent only on the sign 





of the charge of the analyte. Further, it should be noted that the LE, TE, and analyte must have 
the same sign of charge. Flow profiles of fluorescently tagged analytes were imaged using a 
fluorescent microscope. 
3.5.2 Concentration of Avidin in Human Serum 
 Due to the high conductivity of the human serum, suppressing bubble formation became 
a priority. As a result, the flowrate of the quinhydrone had to be three times higher than the 
flowrate of the analyte. Specifically, we set the flowrate of the LE, TE, and analyte to 5 uL/min, 
and the flowrate of the quinhydrone to 15 uL/min. 
 










3.5.3 Critical Bubble Voltage 
 The voltage at which bubbles begin to form in the human serum experiment is a major 
physical constraint of the device due to the fact that bubbles create an unpredictable disruption to 
fluid flow. Therefore we investigated the critical bubble voltage. 
 Originally, we attempted to increase the concentration of the quinhydrone, however 
increasing the concentration by 10 times did nothing to change the critical bubble voltage. We 
did determine, however, that the critical bubble voltage can be affected by the flowrate of the 
quinhydrone. 
 We set the flowrate of the LE, TE, and analyte mixed with human serum to 5 μL/min. We 
then varied the flowrate of both quinhydrone inlets from 2 to 35 μL/min. At each flowrate, we 
increased the voltage by 5 until bubbles began to form.  
3.5.4 Separation Experiments 
 We conducted separation experiments by flowing quinhydrone through channels 1 and 5. 
We simultaneously flow LE through channel 2, and the TE mixed with analytes through channel 
4. During separation experiments, we plugged channel 3. We applied the same flow rate ratios. 
Further, the same voltage ranges were used to induce stacking. The voltage was applied such that 




















4.1 Dye Focusing 
 Dye focusing had already been shown to be possible in our previous correspondences.13 
We have furthered this work to show that dye focusing is possible without pre-mixing of the 
tailing electrolyte and the analyte. 
          
  
Figure 7: A fluorescent image of fluorescein focusing experiment without pre-sample 
mixing. Top left (7A) 2 μL/min, 0V. Top right (7B) 2 μL/min, 50 V. Bottom left (7C) 





 Further, we have mathematically modeled the average intensity increase (AII) as a 
function of both voltage and volume flowrate. In short, we calculate AII by finding the average 
intensity of the dye at 0V, and then subtract this intensity off of each individual point in the 
intensity profile. From here, we found the average of all points remaining that are above 0. We 
modeled this as a decaying exponential function in the following: 
Concentration of Fluroscein
at Various Flow Rates













































Figure 8: AII as a function of voltage over 4 separate flowrates. n=5 
The generalized equation for such a model is: 
𝐴𝐼𝐼 = 𝐴0 ∗ (1 − exp(−𝑘 ∗ 𝑉)) + 𝐶  (Equation 6) 
Where: 
AII is the average intensity increase 
A0, C, and k are fitted constants 
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K is a fitted constant 
V is the voltage applied 
Further, we found that k is a decaying exponential of the volumetric flowrate: 
𝑘 = 𝑘0 ∗ exp (−𝑘′ ∗ ?̇?) (Equation 7) 
Where: 
k is the decaying exponential from the AII equation 
k0 is an experimentally determined constant, which represents the theoretical k at 0 μL/min 
k’ is the exponential decay constant of k, and is also experimentally determined 
V̇ is the volumetric flow rate 
We graph k for 4 separate flow rates below: 
 





𝐴𝐼𝐼 = 𝐴0 ∗ (1 − exp(−(𝑘0 ∗ exp(𝑘
′ ∗ 𝑉)) ∗ 𝑉)) + 𝐶 (Equation 8) 
4.2 Dye Separation 
 We repeated the dye separation experiment as performed in the past.13 In this particular 
case, however, we used fluorescein and rhodamine B, rather than fluorescein and Alexa 591. 
    
Intensity as a Function of
Position before Separation














Intensity as a Function of
Position after Separation
















Figure 10: A fluorescent image of the dye separation experiment with pre-sample mixing. 
Top left (10A) 5 μL/min, 0V. Top right (10B) 5 μL/min, 200 V. Bottom left (10C) 





 It is important to note the parameters of this experiment, we achieved separation at 200V 
and 5 μL/min. In past experiments, separation required 1800V in order to be effective at a 
flowrate of .5 μL/min. 
4.3 Protein Focusing 
 We determined the next major step in the progression of our experiment to be the 
concentration of a protein in DI water. We achieved this utilizing the same setup as the 
concentration of dyes. In this case, we replaced the fluorescein with avidin-FITC. 
   
 
Figure 11: A fluorescent image of the protein separation experiment without pre-sample 
mixing. Top left (11A) 5 μL/min 0V. Top right (11B) 5 μL/min 100 V. Bottom left (11C) 






4.4 Protein Focusing in Serum 
 We decided it is important to explore the efficacy of our technology within a biologically 
relevant media. Thus, we repeated our avidin-FITC focusing experiment in human serum. All 




Figure 12: A fluorescent image of the protein concentration experiment within human 
serum. Top left (12A) 5 μL/min, 0V. Top right (12B) 5 μL/min, 100 V. Bottom left (12C) 






4.5 Critical Bubble Voltage 
 By altering the flowrate of quinhydrone, and slowly increasing the voltage applied across 
the channel, we were able to determine the critical bubble voltage at various flowrates. 
 
Figure 13: Critical bubble voltage as a function of quinhydrone flowrate. Flowrate of TE, 




Critical Bubble Voltage as a Function
of the Fraction of Quinhydrone
Flowrate to Analyte Flowrate
































5.1 Dye Focusing 
 The change in methodology represents an improvement over our previous experimental 
setup. Removing the pre-mixing of the analyte and the TE makes our experiment easier to use, 
reducing the probability of human error. Further, considering the fact that pre-experimental steps 
are generally more time intensive than running microfluidic devices, the removal of the pre-
mixing step will make future devices that utilize this technology more time efficient.  
The development of a mathematical model improves our general understanding of the 
technology, making practical applications more attainable. Although our model is exclusively 
empirical, it is the first step in the direction of the development of a physical model, which 
would shine light on the significance of the constants in equation 8, and potentially further our 
understanding of the physical limitations of the device.  
5.2 Dye Separation 
 The reduction in the required voltage to achieve separation represents an improvement in 
the efficiency of the device. This improved efficiency likely stems from improved fabrication 
techniques of both the carbon black application and the gallium injection. More specifically, less 
air bubbles get trapped between the electrode and the main channel when applying the carbon 
black doped PDMS, and less air bubbles get trapped when injecting the gallium. Both of these 
improvements in technique improve the electrical efficiency of the device. Finally, replacing 
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Alexa 591 with rhodamine B shows that our technology is capable of functioning with analytes 
that have a formal charge of 0. 
 From a qualitative standpoint, the separation was also quite effective. The majority of the 
area under the green curve does not interact with the area under the red curve in figure 12D. 
5.3 Protein Focusing 
 Transitioning from dye to protein focusing presented a myriad of theoretical challenges. 
These challenges primarily arise from the fact that the electrophoretic mobility of a protein is 
heavily dependent on its conformation. Therefore, environmental factors including: heating, pH, 
and ionic strength can heavily influence the results of an experiment. 
 We plan to overcome the environmental dependency by moving into human serum (see 
below), and eventually into whole blood. Further, the challenge of denaturing due to Ohmic 
heating highlights the value of the carbon black membrane. By reducing the overall required 
voltage, the carbon black membrane mitigates the effects of Ohmic heating of the device. 
5.4 Human Serum 
 Changing the media from DI water to human serum drastically increased the conductivity 
from electrode to electrode. As a result, bubbles began to form at a significantly lower threshold 
voltage due to the electrolysis of water. The lower bubble threshold not only reduces the efficacy 
of our technology, but also reduces the reliability as well. Not every device is exactly the same, 
and therefore the critical bubble voltage will change slightly from device to device. Theories for 




 We partially combatted the formation of bubbles by increasing the flowrate of 
quinhydrone. This comes with the unfortunate side effect of pinching the analyte flow stream. 
This results in lower quality focusing, due to how tightly packed the input stream is upon 
entering the device in conjunction with physical packing limitations of dyes, proteins, and other 
analyes. 
5.5 Critical Bubble Voltage 
 At a very low quinhydrone flowrate, the analyte takes up the majority of the channel, this 
area of high conductivity creates a very low critical bubble voltage. As the flowrate increases, 
the analyte takes up less of the main channel, and therefore, due to the overall lower conductivity 
through the channel, bubbles begin to form at a higher voltage threshold. As the analyte flow 
stream becomes more pinched, increasing the flow rate of the quinhydrone does little to improve 
the critical bubble voltage. 
 We found that we can achieve a voltage of 100V when the flow rate of quinhydrone is 3 
times the flowrate of the analyte. Though our tests are possible at this voltage, and flow rate 









 Our long term goal is to develop a microfluidic device capable of monitoring the health 
of astronauts during long missions to deep space. We define the success of our device by its 
spatial efficiency, cost efficiency, weight efficiency, and its ease of use. In this correspondence, 
we improved on our previous method of utilizing ITP to develop a simultaneous western blot, 
and gel electrophoresis replacement. Our improvements include the development of a 
mathematical model to describe dye focusing, and overcoming challenges, and displaying 
efficacy in focusing protein focusing both in DI water, and human serum. Further, we have 
displayed the importance of high quality fabrication within these types of microfluidic devices, 
by drastically increasing the efficiency of the separation experiment. Finally, we have 










 In the future, we plan on improving all experiments referenced in this correspondence. 
We plan to develop a physical model that aligns with our mathematical model, and explore the 
implications of the physical limits of the device with this model. This would bring us a step 
closer to developing practical devices with our technology. 
We plan on repeating the dye focusing experiment with proteins, in order to ensure that the 
model we developed for dyes aligns with the model we developed for proteins. Further, we plan 
on expanding our work with proteins and human serum into the separation experiment in order to 
make our work more biologically relevant.  
Due to the immense value gained simply by becoming more familiar with the fabrication 
techniques required to make this device, we plan on developing a less human based technique to 
apply the carbon black PDMS to the device, with the aim of improving overall reliability and 
efficiency. 
In the future, we hope to find an electron acceptor that is more effective than quinhydrone. 
This would come with the benefit of being able to increase the width of the analyte flow stream 
without allowing for bubble formation, improving focusing effectiveness. 
Further, we hope to repeat our work with proteins while using DNA as the analyte, and 
eventually move into using whole blood as the analyte. 
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In the very long term, we hope to determine how reusable our devices are, which could 
improve the devices overall spatial, weight, and cost efficiency. Finally, we hope to remove 
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